Li Si Ming
Li Si Ming — Associate Chief Physician — Urologic Oncology — Peking University Cancer Hospital
Specialties
Chemotherapy, targeted therapy, and immunotherapy for urogenital system tumors and melanoma.
Education
PhD in Oncology from Peking University
Professional Experience
Associate Chief Physician, specializing in chemotherapy, targeted therapy, and immunotherapy for genitourinary system tumors and melanoma. Served as a key sub-investigator in numerous Phase I-III clinical trials of targeted and immunotherapy drugs for genitourinary system tumors and melanoma. Has been awarded the Top Ten Resident Doctor of Peking University and the Young Post Expert of Peking University Cancer Hospital.
Professional Roles
Currently serving as the Deputy Director of the Head and Neck Melanoma Committee of the Beijing Cancer Prevention and Treatment Society, a Standing Member of the Scientific Research and Translation Committee of the Tumor Prevention and Treatment Branch of the Chinese Society of Geriatric Health, a Member of the Renal Cancer Committee of the Chinese Society of Clinical Oncology (CSCO), Secretary of the Rare Kidney Cancer Collaboration Group of the Urogenital Tumor Committee of the Chinese Anti-Cancer Association (CACA), and a Member of the Urologic Tumor Committee of the Beijing Cancer Prevention and Treatment Society.